Financhill
Buy
52

ALGN Quote, Financials, Valuation and Earnings

Last price:
$180.86
Seasonality move :
-0.76%
Day range:
$177.96 - $182.42
52-week range:
$141.74 - $271.59
Dividend yield:
0%
P/E ratio:
32.96x
P/S ratio:
3.39x
P/B ratio:
3.46x
Volume:
1.2M
Avg. volume:
1.1M
1-year change:
-29.46%
Market cap:
$13.1B
Revenue:
$4B
EPS (TTM):
$5.49

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
ALGN
Align Technology
$975.8M $1.99 2.9% 100.44% $227.30
BSX
Boston Scientific
$4.6B $0.67 18.78% 229.3% $116.96
MLSS
Milestone Scientific
$2.5M -$0.01 40.26% -50% $2.13
NVST
Envista Holdings
$606.4M $0.20 0.62% 46.34% $19.04
SOLV
Solventum
$2B $1.22 1.89% 185.16% $81.27
XRAY
Dentsply Sirona
$854.2M $0.30 -5.77% 234.18% $18.14
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
ALGN
Align Technology
$180.94 $227.30 $13.1B 32.96x $0.00 0% 3.39x
BSX
Boston Scientific
$105.26 $116.96 $155.7B 76.83x $0.00 0% 8.93x
MLSS
Milestone Scientific
$0.92 $2.13 $72.4M -- $0.00 0% 8.58x
NVST
Envista Holdings
$18.27 $19.04 $3.1B -- $0.00 0% 1.26x
SOLV
Solventum
$73.09 $81.27 $12.6B 33.84x $0.00 0% 1.53x
XRAY
Dentsply Sirona
$15.98 $18.14 $3.2B -- $0.16 4.01% 0.86x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
ALGN
Align Technology
-- 1.880 -- 0.99x
BSX
Boston Scientific
33.49% 1.029 7.48% 0.68x
MLSS
Milestone Scientific
-- 2.738 -- 0.62x
NVST
Envista Holdings
31.74% 1.341 47.7% 1.68x
SOLV
Solventum
70.81% 0.248 60.15% 0.64x
XRAY
Dentsply Sirona
53.74% 0.205 78.42% 0.56x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
ALGN
Align Technology
$680.1M $135.3M 10.72% 10.72% 13.81% $27.4M
BSX
Boston Scientific
$3.2B $937M 6.35% 9.57% 19.02% $277M
MLSS
Milestone Scientific
$1.6M -$2M -79.98% -79.98% -89.49% -$1M
NVST
Envista Holdings
$336M $47.4M -24.02% -34.78% 6.21% -$5.6M
SOLV
Solventum
$1.1B $152M 3.34% 11.75% 6.86% -$80M
XRAY
Dentsply Sirona
$466M $70M -19.2% -35.57% 7.17% -$12M

Align Technology vs. Competitors

  • Which has Higher Returns ALGN or BSX?

    Boston Scientific has a net margin of 9.52% compared to Align Technology's net margin of 14.45%. Align Technology's return on equity of 10.72% beat Boston Scientific's return on equity of 9.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    BSX
    Boston Scientific
    68.84% $0.45 $33.6B
  • What do Analysts Say About ALGN or BSX?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 25.62%. On the other hand Boston Scientific has an analysts' consensus of $116.96 which suggests that it could grow by 11.12%. Given that Align Technology has higher upside potential than Boston Scientific, analysts believe Align Technology is more attractive than Boston Scientific.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    BSX
    Boston Scientific
    23 3 0
  • Is ALGN or BSX More Risky?

    Align Technology has a beta of 1.682, which suggesting that the stock is 68.174% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.685, suggesting its less volatile than the S&P 500 by 31.536%.

  • Which is a Better Dividend Stock ALGN or BSX?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or BSX?

    Align Technology quarterly revenues are $979.3M, which are smaller than Boston Scientific quarterly revenues of $4.7B. Align Technology's net income of $93.2M is lower than Boston Scientific's net income of $674M. Notably, Align Technology's price-to-earnings ratio is 32.96x while Boston Scientific's PE ratio is 76.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.39x versus 8.93x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.39x 32.96x $979.3M $93.2M
    BSX
    Boston Scientific
    8.93x 76.83x $4.7B $674M
  • Which has Higher Returns ALGN or MLSS?

    Milestone Scientific has a net margin of 9.52% compared to Align Technology's net margin of -89.35%. Align Technology's return on equity of 10.72% beat Milestone Scientific's return on equity of -79.98%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    MLSS
    Milestone Scientific
    73.8% -$0.02 $4.5M
  • What do Analysts Say About ALGN or MLSS?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 25.62%. On the other hand Milestone Scientific has an analysts' consensus of $2.13 which suggests that it could grow by 130.34%. Given that Milestone Scientific has higher upside potential than Align Technology, analysts believe Milestone Scientific is more attractive than Align Technology.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    MLSS
    Milestone Scientific
    1 0 0
  • Is ALGN or MLSS More Risky?

    Align Technology has a beta of 1.682, which suggesting that the stock is 68.174% more volatile than S&P 500. In comparison Milestone Scientific has a beta of 0.934, suggesting its less volatile than the S&P 500 by 6.585%.

  • Which is a Better Dividend Stock ALGN or MLSS?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Milestone Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Milestone Scientific pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or MLSS?

    Align Technology quarterly revenues are $979.3M, which are larger than Milestone Scientific quarterly revenues of $2.2M. Align Technology's net income of $93.2M is higher than Milestone Scientific's net income of -$2M. Notably, Align Technology's price-to-earnings ratio is 32.96x while Milestone Scientific's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.39x versus 8.58x for Milestone Scientific. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.39x 32.96x $979.3M $93.2M
    MLSS
    Milestone Scientific
    8.58x -- $2.2M -$2M
  • Which has Higher Returns ALGN or NVST?

    Envista Holdings has a net margin of 9.52% compared to Align Technology's net margin of 2.92%. Align Technology's return on equity of 10.72% beat Envista Holdings's return on equity of -34.78%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    NVST
    Envista Holdings
    54.47% $0.10 $4.4B
  • What do Analysts Say About ALGN or NVST?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 25.62%. On the other hand Envista Holdings has an analysts' consensus of $19.04 which suggests that it could grow by 4.22%. Given that Align Technology has higher upside potential than Envista Holdings, analysts believe Align Technology is more attractive than Envista Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    NVST
    Envista Holdings
    4 9 1
  • Is ALGN or NVST More Risky?

    Align Technology has a beta of 1.682, which suggesting that the stock is 68.174% more volatile than S&P 500. In comparison Envista Holdings has a beta of 0.975, suggesting its less volatile than the S&P 500 by 2.472%.

  • Which is a Better Dividend Stock ALGN or NVST?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or NVST?

    Align Technology quarterly revenues are $979.3M, which are larger than Envista Holdings quarterly revenues of $616.9M. Align Technology's net income of $93.2M is higher than Envista Holdings's net income of $18M. Notably, Align Technology's price-to-earnings ratio is 32.96x while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.39x versus 1.26x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.39x 32.96x $979.3M $93.2M
    NVST
    Envista Holdings
    1.26x -- $616.9M $18M
  • Which has Higher Returns ALGN or SOLV?

    Solventum has a net margin of 9.52% compared to Align Technology's net margin of 6.62%. Align Technology's return on equity of 10.72% beat Solventum's return on equity of 11.75%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    SOLV
    Solventum
    53.82% $0.78 $11.2B
  • What do Analysts Say About ALGN or SOLV?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 25.62%. On the other hand Solventum has an analysts' consensus of $81.27 which suggests that it could grow by 11.19%. Given that Align Technology has higher upside potential than Solventum, analysts believe Align Technology is more attractive than Solventum.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    SOLV
    Solventum
    1 8 0
  • Is ALGN or SOLV More Risky?

    Align Technology has a beta of 1.682, which suggesting that the stock is 68.174% more volatile than S&P 500. In comparison Solventum has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock ALGN or SOLV?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Solventum offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Solventum pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or SOLV?

    Align Technology quarterly revenues are $979.3M, which are smaller than Solventum quarterly revenues of $2.1B. Align Technology's net income of $93.2M is lower than Solventum's net income of $137M. Notably, Align Technology's price-to-earnings ratio is 32.96x while Solventum's PE ratio is 33.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.39x versus 1.53x for Solventum. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.39x 32.96x $979.3M $93.2M
    SOLV
    Solventum
    1.53x 33.84x $2.1B $137M
  • Which has Higher Returns ALGN or XRAY?

    Dentsply Sirona has a net margin of 9.52% compared to Align Technology's net margin of 2.28%. Align Technology's return on equity of 10.72% beat Dentsply Sirona's return on equity of -35.57%.

    Company Gross Margin Earnings Per Share Invested Capital
    ALGN
    Align Technology
    69.45% $1.27 $3.8B
    XRAY
    Dentsply Sirona
    53.02% $0.10 $4.3B
  • What do Analysts Say About ALGN or XRAY?

    Align Technology has a consensus price target of $227.30, signalling upside risk potential of 25.62%. On the other hand Dentsply Sirona has an analysts' consensus of $18.14 which suggests that it could grow by 13.54%. Given that Align Technology has higher upside potential than Dentsply Sirona, analysts believe Align Technology is more attractive than Dentsply Sirona.

    Company Buy Ratings Hold Ratings Sell Ratings
    ALGN
    Align Technology
    8 6 0
    XRAY
    Dentsply Sirona
    2 13 0
  • Is ALGN or XRAY More Risky?

    Align Technology has a beta of 1.682, which suggesting that the stock is 68.174% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.924, suggesting its less volatile than the S&P 500 by 7.642%.

  • Which is a Better Dividend Stock ALGN or XRAY?

    Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.01% to investors and pays a quarterly dividend of $0.16 per share. Align Technology pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

  • Which has Better Financial Ratios ALGN or XRAY?

    Align Technology quarterly revenues are $979.3M, which are larger than Dentsply Sirona quarterly revenues of $879M. Align Technology's net income of $93.2M is higher than Dentsply Sirona's net income of $20M. Notably, Align Technology's price-to-earnings ratio is 32.96x while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.39x versus 0.86x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    ALGN
    Align Technology
    3.39x 32.96x $979.3M $93.2M
    XRAY
    Dentsply Sirona
    0.86x -- $879M $20M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

2 Ultra Safe Dividend Stocks to Buy Now
2 Ultra Safe Dividend Stocks to Buy Now

Historically, blue-chip dividend stocks have been good choices for periods…

Where Will Asana Stock Be in 5 Years?
Where Will Asana Stock Be in 5 Years?

Asana stock hasn’t given many investors on Wall Street any…

Where Will Dell Stock Be in 5 Years?
Where Will Dell Stock Be in 5 Years?

So you’re looking at Dell (NASDAQ: DELL) and wondering, “Is…

Stock Ideas

Buy
67
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3T
P/E Ratio: 33x

Alerts

Sell
31
REGN alert for May 31

Regeneron Pharmaceuticals [REGN] is down 19.04% over the past day.

Buy
55
RGC alert for May 31

Regencell Bioscience Holdings [RGC] is up 16.13% over the past day.

Sell
42
AMBA alert for May 31

Ambarella [AMBA] is down 15.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock